The EMS Consolidation Decision

A Note on Format

This article is written as a decision memo — the kind I would put in front of a CPO or COO asking the question the title asks. I have kept it in that format intentionally. Most procurement content describes the landscape. This one tries to help you decide.

If you are sitting with an EMS consolidation question right now, you can skip to the options. If you want the framing first, start from the top.

Background

The question of whether to consolidate electronics manufacturing services suppliers is not new. But the context in which procurement leaders are asking it in 2026 is different in ways that matter.

As of this writing, the US average effective tariff rate sits around 16 percent — the highest since the 1930s. Section 232 duties of 25 percent apply to advanced semiconductors. A flat 15 percent Section 122 tariff replaced the IEEPA regime after the Supreme Court ruling, and that tariff is currently scheduled to expire in mid-2026, though nobody I speak with treats that expiration as certain. The US–Taiwan agreement signed in January offers tariff relief for Taiwanese manufacturers who invest in US capacity, creating a bifurcated supply picture even within a single country. Section 301 exclusions on 178 Chinese product categories have been extended to November 2026. China has opened two retaliatory investigations.

None of this is stable. All of it affects EMS sourcing decisions.

The specific question on the table: should you reduce the number of EMS partners you work with to improve leverage, simplify management, and capture volume pricing — or should you maintain or expand your current supplier footprint to preserve flexibility in a tariff environment that changes monthly?

The honest answer is that it depends on three things: your product mix, your end-market geography, and how long you believe the current tariff regime will last. The rest of this memo walks through how to think about each.

Framing the Decision

Before the options, three observations worth stating plainly.

First: consolidation and diversification are not a binary. The real choice is about where you consolidate and where you diversify. Most organizations I have worked with end up needing to do both simultaneously — consolidating within one region while diversifying across regions. The question is not “how many suppliers” but “which shape.”

Second: the tariff regime is not the only variable. Quality, IP protection, engineering capacity, and labor cost trajectories all matter. A decision framed only around tariffs will age badly the moment the tariffs change. The memo below weighs tariffs heavily because that is the question asked, but the actual decision needs to account for the rest.

Third: reversibility matters more than optimization. In a volatile environment, a decision that is slightly suboptimal but easy to reverse is often better than a decision that is optimal under current conditions but expensive to unwind. The options below are ranked partly on this dimension.

The Three Options

Option A: Consolidate to Two Strategic EMS Partners

What it means: Reduce your current EMS footprint to two primary partners — typically one in a lower-cost Asian geography and one nearshore (Mexico, Eastern Europe, or Turkey depending on end market). Shift 80 percent of volume to these two. Retain one or two small suppliers for specialty or redundancy.

The case for it:

Significantly improved commercial leverage. Two partners receiving 40 percent of your volume each will negotiate very differently than five partners receiving 15–20 percent.
Simplified supplier management. Quality systems, engineering collaboration, and compliance processes all scale better with fewer relationships.
Faster engineering cycles. EMS partners with deeper volume commitment invest more in joint engineering and process improvement.
Cost savings in the range of 4–8 percent on affected spend, depending on category and starting fragmentation.

The case against it:

Concentration risk is real and currently elevated. A 25 percent Section 232 duty applied to a category your primary Asian partner handles would immediately erode consolidation savings and create margin pressure you cannot absorb quickly.
Reversibility is poor. Rebuilding a diversified supplier base after consolidation takes 18–24 months and costs qualification expense that your savings numbers did not account for.
In a bifurcated tariff environment like the current US–Taiwan structure, consolidating into a single Taiwanese partner without understanding their US investment commitments can lock you into the wrong side of a future duty change.

Risk profile: Medium-to-high. Savings are real and near-term. Downside is slow to appear and expensive to correct.

Option B: Maintain or Expand Current Footprint

What it means: Keep your existing EMS supplier base intact, or add one or two new suppliers in regions you are not currently sourcing from (Vietnam, India, additional Eastern European options). Accept higher management overhead and lower per-supplier leverage in exchange for optionality.

The case for it:

Maximum flexibility to respond to tariff changes. If a new duty hits one region, you can shift volume to another supplier already qualified and producing.
Lower single-point-of-failure risk on both tariff and non-tariff disruptions.
Strategic optionality during a period when the rules are genuinely uncertain.

The case against it:

Meaningful cost premium. Fragmented volume means weaker commercial terms and duplicate qualification costs. I would estimate 3–6 percent higher total cost on affected spend versus Option A.
Engineering attention is spread thin. EMS partners working with many customers prioritize those who matter most to their volume. If you are one of several small customers at five suppliers, you are rarely anyone’s priority.
Management overhead is real and often underestimated. Each additional EMS partner requires quality audits, compliance monitoring, and relationship investment.

Risk profile: Low-to-medium. Costs are certain and ongoing. Protection against tariff volatility is real but expensive.

Option C: Regionalize — Align EMS Footprint to End-Market Tariff Zones

What it means: Instead of thinking about total supplier count, restructure the footprint so that each major end market is served primarily by EMS capacity inside or closely aligned with that market’s tariff zone. US-market products built in Mexico or Taiwan (with US investment commitments qualifying for preferential rates). EU-market products built in Eastern Europe or Turkey. Asia-market products built regionally.

The case for it:

Tariff exposure is structurally reduced, not just hedged. Products designed for a market are built in the region that market treats preferentially.
Consolidation benefits within each region are preserved — you still get leverage from two or three partners per region rather than spreading thin.
Reversibility is strong. If tariff zones shift, you can rebalance within region faster than you can restructure across regions.
Aligns with where most major customers will expect suppliers to end up over the next three to five years regardless of the immediate tariff picture.

The case against it:

It is the most operationally complex of the three options. Regionalization requires redesigning some products, re-qualifying suppliers, and building new management rhythms.
Short-term cost impact is negative. Expect a 2–4 percent cost increase during the transition period, lasting 12–18 months.
Requires cross-functional alignment — engineering, finance, operations, and commercial all have to move together. This is a political lift, not just a procurement decision.

Risk profile: Low. Higher short-term cost, but the structural position is stronger and more durable than either alternative.

The Recommendation

Option C — with a qualification.

Regionalization is the only option that addresses the actual shape of the problem rather than just hedging against one dimension of it. Consolidation optimizes for a commercial environment that may not exist in six months. Pure diversification protects against volatility at a permanent cost premium. Regionalization restructures the footprint to be less sensitive to the specific tariff regime in force at any given moment.

But regionalization is only the right answer if your organization can actually execute it. The memo’s qualification is this: Option C requires cross-functional commitment that procurement alone cannot deliver. If engineering will not redesign products for regional manufacturing, if finance will not absorb 12–18 months of transition cost, if operations will not invest in managing three regional supply bases instead of one global one — then Option C becomes a PowerPoint strategy, not a real one.

In that case, the second-best answer is Option A with explicit tariff insurance — consolidate to two strategic partners, but retain one qualified alternate per category in a different tariff zone, and contractualize the right to shift volume on defined triggers. This is not as structurally sound as Option C, but it is executable inside procurement’s authority.

Option B is rarely the right answer for more than a transition period. The cost premium compounds, and the optionality it preserves is usually cheaper to buy through contract terms than through permanent supplier fragmentation.

How to Decide: Five Questions

A decision like this cannot be made from a memo alone. Before committing, the procurement team and executive sponsors should answer these five questions honestly.

1. How long do you believe the current tariff regime will persist? If the answer is “18 months or less,” Option A with insurance is defensible. If the answer is “three years or more,” Option C is almost certainly correct.

2. What is your product portfolio’s sensitivity to regional design? Products with minimal regional variation are easier to regionalize. Products built to market-specific standards are already partly there.

3. Can engineering deliver regional variants without doubling development cost? If no, Option C is not feasible and the question becomes how to execute Option A defensively.

4. How much short-term margin pressure can the business absorb? Option C costs money before it saves money. If the next four quarters are tight, the decision window may not be open.

5. What is your competitors’ likely move? If your primary competitors are regionalizing, staying consolidated creates a structural disadvantage. If they are consolidating, your regionalization creates a differentiation opportunity.

Key Takeaways

Consolidation and diversification are not a binary. The real question is the shape of the supplier base, not the count.
Option A (consolidation) offers 4–8% savings but carries elevated tariff concentration risk in the current 2026 environment, and is expensive to reverse.
Option B (diversification) preserves flexibility at a 3–6% cost premium and is rarely the right long-term answer outside transition periods.
Option C (regionalization) is the recommended path because it restructures the footprint rather than hedging against a volatile tariff regime — but it requires cross-functional commitment beyond procurement’s authority.
Reversibility matters more than optimization in a volatile environment. A slightly suboptimal decision that is easy to unwind is usually better than an optimal one that is hard to reverse.
If Option C is not executable, the second-best answer is Option A with explicit tariff insurance — consolidation with contractually-defined volume shift rights to alternate tariff zones.
The decision depends on three inputs: how long you believe the tariff regime will last, whether engineering can deliver regional product variants, and how much short-term margin pressure the business can absorb.

Closing Note

I want to end where I started. This is a decision memo, not a forecast. I have no particular confidence that the tariff regime in place as I write this will look the same in six months. What I do believe is that procurement leaders who wait for clarity before deciding will find that clarity never arrives, and the decision gets made for them by events.

The best procurement decisions in volatile environments are not the ones that predict the future correctly. They are the ones that remain defensible across several plausible futures. Option C is recommended because it is the most robust, not because it is the most clever.

Whichever option you choose, document the reasoning. In eighteen months, when the tariff picture has shifted again, the organizations that can explain why they decided what they decided will adapt faster than the ones that only remember what they decided.